WVE

Wave Life Sciences Ltd.

4.16 USD
+0.17 (+4.26%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Wave Life Sciences Ltd. stock is down -8.97% since 30 days ago. The next earnings date is Mar 20, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 66.67% of the previous 8 February’s closed higher than January.

About Wave Life Sciences Ltd.

Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides. The company also develops WVE-004, a C9orf72 molecule for the treatment of amyotrophic lateral sclerosis and frontotemporal dementia. It focuses on developing GalNAc-conjugated AIMers to treat hepatic indications.